These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 28538024)

  • 21. Efficacy and safety of vilazodone in major depressive disorder: a randomized, double-blind, placebo-controlled trial.
    Croft HA; Pomara N; Gommoll C; Chen D; Nunez R; Mathews M
    J Clin Psychiatry; 2014 Nov; 75(11):e1291-8. PubMed ID: 25470094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early and sustained improvement with vilazodone in adult patients with major depressive disorder: post hoc analyses of two phase III trials.
    Jain R; Chen D; Edwards J; Mathews M
    Curr Med Res Opin; 2014 Feb; 30(2):263-70. PubMed ID: 24127687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of vilazodone for major depressive disorder: evidence from phase III/IV randomized controlled trials.
    Shi L; Wang J; Xu S; Lu Y
    Drug Des Devel Ther; 2016; 10():3899-3907. PubMed ID: 27932864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.
    Emslie GJ; Prakash A; Zhang Q; Pangallo BA; Bangs ME; March JS
    J Child Adolesc Psychopharmacol; 2014 May; 24(4):170-9. PubMed ID: 24815533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trial.
    Rickels K; Athanasiou M; Robinson DS; Gibertini M; Whalen H; Reed CR
    J Clin Psychiatry; 2009 Mar; 70(3):326-33. PubMed ID: 19284933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine.
    Gibbons RD; Brown CH; Hur K; Davis J; Mann JJ
    Arch Gen Psychiatry; 2012 Jun; 69(6):580-7. PubMed ID: 22309973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder.
    Atkinson SD; Prakash A; Zhang Q; Pangallo BA; Bangs ME; Emslie GJ; March JS
    J Child Adolesc Psychopharmacol; 2014 May; 24(4):180-9. PubMed ID: 24813026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder.
    Strawn JR; Prakash A; Zhang Q; Pangallo BA; Stroud CE; Cai N; Findling RL
    J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):283-93. PubMed ID: 25791145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder.
    Sahli ZT; Banerjee P; Tarazi FI
    Expert Opin Drug Discov; 2016; 11(5):515-23. PubMed ID: 26971593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment-emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial.
    Rucci P; Frank E; Scocco P; Calugi S; Miniati M; Fagiolini A; Cassano GB
    Depress Anxiety; 2011 Apr; 28(4):303-9. PubMed ID: 21308882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.
    KoKoAung E; Cavenett S; McArthur A; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials.
    Carpenter DJ; Fong R; Kraus JE; Davies JT; Moore C; Thase ME
    J Clin Psychiatry; 2011 Nov; 72(11):1503-14. PubMed ID: 21367354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of vilazodone for the acute treatment of generalized anxiety disorder: A meta-analysis.
    Zareifopoulos N; Dylja I
    Asian J Psychiatr; 2017 Apr; 26():115-122. PubMed ID: 28483071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment-emergent sexual dysfunction in randomized trials of vortioxetine for major depressive disorder or generalized anxiety disorder: a pooled analysis.
    Jacobsen PL; Mahableshwarkar AR; Palo WA; Chen Y; Dragheim M; Clayton AH
    CNS Spectr; 2016 Oct; 21(5):367-378. PubMed ID: 26575433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder.
    Reed CR; Kajdasz DK; Whalen H; Athanasiou MC; Gallipoli S; Thase ME
    Curr Med Res Opin; 2012 Jan; 28(1):27-39. PubMed ID: 22106941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorder.
    Stein DJ; Lopez AG
    Adv Ther; 2011 Nov; 28(11):1021-37. PubMed ID: 22057726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suicide rates in short-term randomized controlled trials of newer antidepressants.
    Hammad TA; Laughren TP; Racoosin JA
    J Clin Psychopharmacol; 2006 Apr; 26(2):203-7. PubMed ID: 16633153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal analyses of depression, anxiety, and suicidal ideation highlight greater prevalence in the northern Dutch population during the COVID-19 lockdowns.
    Ori APS; Wieling M; ; van Loo HM
    J Affect Disord; 2023 Feb; 323():62-70. PubMed ID: 36427649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind switch study of vilazodone in the treatment of major depressive disorder.
    Grant JE; Redden SA; Leppink EW
    Int Clin Psychopharmacol; 2017 May; 32(3):121-126. PubMed ID: 28177953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Double-Blind, Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Posttraumatic Stress Disorder and Comorbid Depression.
    Ramaswamy S; Driscoll D; Reist C; Smith LM; Albers LJ; Rose J; Nguyen L; Monga V; Doria R; Hollifield M
    Prim Care Companion CNS Disord; 2017 Aug; 19(4):. PubMed ID: 28858440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.